Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Tibshirani

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Biology of the Cell|March 23, 2004
Different gene expression patterns in invasive lobular and ductal carcinomas of the breastHongjuan Zhao, Anita Langerød, Youngran Ji, et al.
The American Journal of Pathology|April 26, 2007
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumorsNorman L Lehman, Rob Tibshirani, Jerry Y Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2011
MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOPAlvaro J Alencar, Raquel Malumbres, Goldi A Kozloski, et al.
Blood|May 1, 2008
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOPRaquel Malumbres, Jun Chen, Rob Tibshirani, et al.
The American Journal of Pathology|December 6, 2002
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeMatt van de Rijn, Charles M Perou, Rob Tibshirani, et al.
Epidemics|March 7, 2018
Results from the second year of a collaborative effort to forecast influenza seasons in the United StatesMatthew Biggerstaff, Michael Johansson, David Alper, et al.
American Journal of Obstetrics and Gynecology|December 27, 2017
A proteomic clock of human pregnancyNima Aghaeepour, Benoit Lehallier, Quentin Baca, et al.
Cancer Cell|July 11, 2023
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2010
Analysis of factorial time-course microarrays with application to a clinical study of burn injuryBaiyu Zhou, Weihong Xu, David Herndon, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Biology of the Cell|March 23, 2004
Different gene expression patterns in invasive lobular and ductal carcinomas of the breastHongjuan Zhao, Anita Langerød, Youngran Ji, et al.
The American Journal of Pathology|April 26, 2007
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumorsNorman L Lehman, Rob Tibshirani, Jerry Y Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2011
MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOPAlvaro J Alencar, Raquel Malumbres, Goldi A Kozloski, et al.
Blood|May 1, 2008
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOPRaquel Malumbres, Jun Chen, Rob Tibshirani, et al.
The American Journal of Pathology|December 6, 2002
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeMatt van de Rijn, Charles M Perou, Rob Tibshirani, et al.
Epidemics|March 7, 2018
Results from the second year of a collaborative effort to forecast influenza seasons in the United StatesMatthew Biggerstaff, Michael Johansson, David Alper, et al.
American Journal of Obstetrics and Gynecology|December 27, 2017
A proteomic clock of human pregnancyNima Aghaeepour, Benoit Lehallier, Quentin Baca, et al.
Cancer Cell|July 11, 2023
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2010
Analysis of factorial time-course microarrays with application to a clinical study of burn injuryBaiyu Zhou, Weihong Xu, David Herndon, et al.
Pageof 3